These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8627453)

  • 1. Differences in immunoglobulin preparations and outcome of Kawasaki disease.
    Yavuz H; Ozel A
    J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma exchange in Kawasaki disease.
    Takagi N; Kihara M; Yamaguchi S; Tamura K; Yabana M; Tokita Y; Ishii M
    Lancet; 1995 Nov; 346(8985):1307. PubMed ID: 7475760
    [No Abstract]   [Full Text] [Related]  

  • 3. [Updates on diagnosis and management of Kawasaki disease unresponsive to intravenous gamma globulin].
    Wang YQ; Cao XJ
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):226-8. PubMed ID: 15833210
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gamma globulins and Kawasaki disease].
    Musumeci S; Fischer A; Di Dio R
    Pediatrie; 1986 Jun; 41(4):333-5. PubMed ID: 2433677
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for intravenous immunoglobulin therapy of Kawasaki disease.
    Shulman ST
    Pediatr Infect Dis J; 1992 Nov; 11(11):985-6. PubMed ID: 1454455
    [No Abstract]   [Full Text] [Related]  

  • 6. The mechanism of efficacy of intravenous immunoglobulin in Kawasaki disease.
    Kaneka K; Savage CO; Pottinger BE; Shah V; Pearson JD; Dillon MJ
    Pediatr Infect Dis J; 1994 Nov; 13(11):1022-3. PubMed ID: 7845731
    [No Abstract]   [Full Text] [Related]  

  • 7. Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage.
    Singh S; Kumar L
    Indian Pediatr; 1996 Aug; 33(8):689-92. PubMed ID: 8979554
    [No Abstract]   [Full Text] [Related]  

  • 8. Kawasaki disease in a two-month-old infant.
    Nso Roca AP; Aracil Santos FJ; del Castillo Martín F; García Guereta L
    Turk J Pediatr; 2010; 52(2):227-8. PubMed ID: 20560266
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis.
    Meissner HC; Schlievert PM; Leung DY
    Immunol Rev; 1994 Jun; 139():109-23. PubMed ID: 7927408
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Kawasaki disease.
    Glode MP; Burns JC
    Pediatr Infect Dis J; 1992 Mar; 11(3):249-50. PubMed ID: 1565549
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of immunoglobulin retreatment in Kawasaki disease.
    Falcini F; Ermini M; Trapani S; Taccetti G
    J Pediatr; 1994 Oct; 125(4):672-3. PubMed ID: 7931898
    [No Abstract]   [Full Text] [Related]  

  • 12. IVIG, aspirin, and Kawasaki disease.
    Morgan GJ; MacLeod C; Jenkins J; Stewart C; Craig B
    J Pediatr; 2003 Aug; 143(2):280-1; author reply 281. PubMed ID: 12970651
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment.
    Fujimoto N; Teramura K; Tanaka T
    J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144
    [No Abstract]   [Full Text] [Related]  

  • 14. Kawasaki disease in a preterm neonate: Case report and cytokine profile.
    Okazaki K; Matsui K; Takahashi N; Miura M; Kondo M
    Pediatr Int; 2018 Nov; 60(11):1037-1039. PubMed ID: 30378211
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease.
    Nishihara S; Ishibashi K; Iribe K; Matsuda I
    Lancet; 1988 Oct; 2(8617):973. PubMed ID: 2459575
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of Kawasaki disease.
    Sagraves R
    J Pediatr Health Care; 1993; 7(6):278-82. PubMed ID: 8106928
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.
    Yoshida S; Sakurai Y; Takeda T; Fukuda K
    J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975
    [No Abstract]   [Full Text] [Related]  

  • 19. Gamma globulin re-treatment in Kawasaki disease.
    Sundel RP; Burns JC; Baker A; Beiser AS; Newburger JW
    J Pediatr; 1993 Oct; 123(4):657-9. PubMed ID: 8410524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin dose for treatment of Kawasaki disease.
    Krasemann T
    Arch Dis Child; 2015 Mar; 100(3):300. PubMed ID: 25409983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.